structure of 78 44 4 - Carisoprodol CAS 78-44-4

Iden­ti­fi­ca­tion

CAS Number

78-44-4

Name

Cariso­prodol

Syn­onyms

Val­i­dat­ed by Experts, Val­i­dat­ed by Users, Non-Val­i­­dat­ed, Removed by Users
(1-méthyléthyl)carbamate de 2-[(carbamoyloxy)méthyl]-2-méthylpentyle [French]
2-[(carbamoyloxy)methyl]-2-methylpentyl (1-methylethyl)carbamate
2-[(Carbamoyloxy)methyl]-2-methylpentyl iso­propy­l­car­ba­mate [ACD/IUPAC Name]
2-[(Carbamoyloxy)methyl]-2-methylpentyl-(1-methylethyl)carbamat [Ger­man]
2-[(Carbamoyloxy)methyl]-2-methylpentyl-isopropylcarbamat [Ger­man] [ACD/IUPAC Name]
2-{[(aminocarbonyl)oxy]methyl}-2-methylpentyl iso­propy­l­car­ba­mate
200-659-6 [EINECS]
201-118-7 [EINECS]
2-Methyl-2-propyl-1,3-propanediol car­ba­mate iso­propy­l­car­ba­mate
78-44-4 [RN]
Car­bam­ic acid, (1-methylethyl)-, 2-(((aminocarbonyl)oxy)methyl)-2-methylpentyl ester
car­bam­ic acid, (1-methylethyl)-, 2-[[(aminocarbonyl)oxy]methyl]-2-methylpentyl ester
Car­bam­ic acid, N-(1-methylethyl)-, 2-[[(aminocarbonyl)oxy]methyl]-2-methylpentyl ester [ACD/​Index Name]
Cari­so­ma [Trade name]
cariso­prodol [BAN] [INN] [USAN] [Wiki]
cariso­prodol [French] [INN]
cariso­prodol [Span­ish] [INN]
Cariso­prodol, (S)-
cariso­prodolum [Latin] [INN]
Iso­propy­l­car­ba­mate de 2-[(carbamoyloxy)méthyl]-2-méthylpentyle [French] [ACD/IUPAC Name]
MFCD00057661 [MDL num­ber]
Sanoma [Trade name]
Soma [Trade name]
каризопродол [Russ­ian] [INN]
كاريزوبرودول [Ara­bic] [INN]
卡立普多 [Chi­nese] [INN]
(±)-2-Methyl-2-propyl-1,3-propanediol car­ba­mate iso­propy­l­car­ba­mate
(1-Methylethyl)carbamic acid 2-(((aminocarbonyl)oxy)methyl)-2-methylpentyl ester
(1-Methylethyl)carbamic Acid 2-[[(Aminocarbonyl)oxy]methyl]-2-methylpentyl Ester
(RS)-2-{[(aminocarbonyl)oxy]methyl}-2-methylpentyl iso­propy­l­car­ba­mate
[2-(carbamoyloxymethyl)-2-methyl-pentyl] N-iso­propy­­l­­car­ba­­mate
[2-(carbamoyloxymethyl)-2-methylpentyl] N-propan-2-ylcar­ba­­mate
[2-methyl-2-({[(propan-2-yl)carbamoyl]oxy}methyl)pentyl] car­ba­mate
[78-44-4] [RN]
1, 3-Propane­di­ol, 2-methyl-2-propyl-, car­ba­mate iso­propy­l­car­ba­mate
1,3-Propanediol, 2-methyl-2-propyl-, car­ba­mate iso­propy­l­car­ba­mate
1215602-82-6 [RN]
1218911-16-0 [RN]
1218911-70-6 [RN]
1-Methylethyl­­car­bam­ic acid 2-{[(aminocarbonyl)oxy]methyl}-2 -methylpentyl ester
2-((Carbamoyloxy)methyl)-2-methylpentyl iso­propy­l­car­ba­mate
2-[(carbamoyloxy)methyl]-2-methylpentyl N-(propan-2-yl)carbamate
2-[(carbamoyloxy)methyl]-2-methylpentyl propan-2-ylcar­ba­­mate
201-118-7MFCD00057661
25462-17-3 [RN]
2-methyl-2-({[(propan-2-yl)carbamoyl]oxy}methyl)pentyl car­ba­mate
2-methyl-2-{[N-(methylethyl)carbamoyloxy]methyl}pentyl aminooate
2-methyl-2-propy­­ltrimeth­yl­ene car­ba­mate iso­propy­l­car­ba­mate
4-04-00-00520 [Beil­stein]
8053-63-2 [RN]
8067-69-4 [RN]
Ape­san
Arti­far
Arusal
Aton­a­lyt
Bri­an­il
Calen­fa
Capro­dat
car­bam­ic acid 2-iso­propy­­l­­car­bamoy­loxymethyl-2-methyl-pentyl ester
Car­bam­ic acid, iso­propyl-, 2-(hydroxymethyl)-2-methylpentyl ester car­ba­mate
Car­bam­ic acid, iso­propyl-, 2-(hydroxymethyl)-2-methylpentyl ester, car­ba­mate
Cari­dolin
Carisol
Cariso­pro­date
Cariso­pro­da­tum
CARISO­PRODOL-D3
CARISO­PRODOL-D7
Cariso­prodol-d7 (propyl-d7) (CRM)
Cariso­prodolmiss­ing
Cariso­prodolo [DCIT]
Cariso­prodolum
Carl­sodol
Carl­so­ma
Carl­so­prol
Car­so­dal
Car­sodol
Chinchen
Copro­bate
DB00395
Dio­lene
Domarax
Fibrosona
Flex­ag­ilt
Flex­ag­it
Flex­al
Flexar­tal
Flexar­tel
Flex­i­don
Gen­cari
Gene­safe
Hiranin
Isoba­mate
Isomeproba­mate
Iso­propyl meproba­mate
Iso­propy­lmeproba­mate
Iso­protan
Iso­protane
Iso­pro­thane
Izo­protan
Listaflex
Mediquil
Mepro­dat
Mioar­t­ri­na
Mioliso­dal
Miolisodol
Mio­ra­t­ri­na
Mio­r­il
Mio­r­i­odol
Mus­lax
N-(1-methylethyl)-2-[[(aminocarbonyl)oxy]methyl]-2-methylpentyl ester-car­bam­ic acid
N-(1-Methylethyl)carbamic acid 2-[[(aminocarbonyl)oxy]methyl]-2-methylpentyl ester
N-(1-methylethyl)-carbamic acid, 2-[[(aminocarbonyl)oxy]methyl]-2-methylpentyl ester
Neot­i­ca
N-isopropy-2-methyl-2-propyl-1,3-propanediol dicar­ba­mate
N-Isopropyl-2-methyl-2-propyl-1,3-propanediol dicar­ba­mate
N-Isopropyl-2-methyl-2-propyl-1,3-propanediol, dicar­ba­mate
N-propan-2-ylcar­bam­ic acid [(2R)-2-(carbamoyloxymethyl)-2-methylpentyl] ester
RELA
Rela­som
Scu­­tamil-C
Sku­tamil
Soma- Carisoprodol CAS 78-44-4
Somadril
Soma­l­git
Somanil
Someproba­mate
Stial­gin
Ten­saprin
Tonolyt iso­propyl meproba­mate
WLN : ZVO1X3&1&1OVMY1&1

SMILES

CCCC(C)(COC(=O)N)COC(=O)NC(C)C

Std­InChI

InChI=1S/C12H24N2O4/c1-5-6-12(4,7-17-10(13)15)8-18-11(16)14-9(2)3/h9H,5-8H2,1-4H3,(H2,13,15)(H,14,16)

Std­InChIKey

OFZ­­CIYF­F­PZC­N­­JE-UHF­F­­FAOYSA-N

Mol­e­c­u­lar Formula

C12H24N2O4

Mol­e­c­u­lar Weight

260.330

EINECS

201-118-7

Prop­er­ties

Appear­ance

White crys­talline powder

Melt­ing Point

91.0°C to 94.0°C

Safe­ty Data

WGK Germany

3

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our 

Iden­ti­fi­ca­tion Methods

HNMR, HPLC

Iden­ti­fi­ca­tion

1. Infrared absorp­tion spec­troscopy : The infrared absorp­tion spec­trum is con­cor­dant with the Cariso­prodol work­ing standard.

2. Thin lay­er chro­matog­ra­phy : The Rr val­ue of the sam­ple should cor­re­spond to that of work­ing standard.

Puri­ty

98% min

Heavy Met­als

NMT 0.001%

Lim­it of meprobamate

NMT 0.5%

Methanol

NMT 1000 ppm

Iso­propyl alcohol

NMT 1000 ppm

Chlo­ro­form

NMT60 ppm

Toluene

NMT 500 ppm

Benzene(As impu­ri­ty in Toluene)

NMT 2 ppm

Loss on Drying

NMT 0.5% w/​w

Shelf Life

4 years

Stor­age

Pre­serve in tight con­tain­er at room temperature,away from light

Known Appli­ca­tion

Carisoprodol, sold under the brand name Soma among others, is a medication used for musculoskeletal pain. Use is only approved for up to three weeks. Effects generally begin within half an hour and last for up to six hours. It is taken orally.

Common side effects include headache, dizziness, and sleepiness. Serious side effect may include addiction, allergic reactions, and seizures. In people with a sulfa allergy certain formulations may result in problems. Safety during pregnancy and breastfeeding is not clear. How it works is not clear. Some of its effects are believed to occur following being converted into meprobamate.

Carisoprodol was approved for medical use in the United States in 1959. Its approval in the European Union was withdrawn in 2008. It is available as a generic medication. In 2019, it was the 343rd most commonly prescribed medication in the United States, with more than 800 thousand prescriptions. In the United States, it is a Schedule IV controlled substance.

This prod­uct is devel­oped by our R&D com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Lim­it­ed (http://​www​.cam​ing​.com/).

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you shortly.

























    Please prove you are human by select­ing the Car.